Avidity AOC 1020 Investor Presentation Clinical Development

Avidity presents its virtual investor and analyst event focused on advancing AOC 1020, a product candidate from its RNA therapeutic platform, toward clinical development. The company discusses forward-looking development timelines, trial design, and its vision to improve patient outcomes through innovative RNA delivery technologies.